109 related articles for article (PubMed ID: 8993559)
1. Peroxisome proliferators and signal transduction.
Bronfman M; Nuñez L; Orellana A; Burzio V; Hidalgo P
Ann N Y Acad Sci; 1996 Dec; 804():403-12. PubMed ID: 8993559
[No Abstract] [Full Text] [Related]
2. Perfluorooctane sulfonic acid is a potent inducer of peroxisomal fatty acid beta-oxidation and other activities known to be affected by peroxisome proliferators in mouse liver.
Sohlenius AK; Eriksson AM; Högström C; Kimland M; DePierre JW
Pharmacol Toxicol; 1993 Feb; 72(2):90-3. PubMed ID: 8386358
[TBL] [Abstract][Full Text] [Related]
3. Ciprofibrate, a carcinogenic peroxisome proliferator, increases the phosphorylation of epidermal-growth-factor receptor in isolated rat hepatocytes.
Orellana A; Holuigue L; Hidalgo PC; Faúndez V; González A; Bronfman M
Eur J Biochem; 1993 Aug; 215(3):903-6. PubMed ID: 8354295
[TBL] [Abstract][Full Text] [Related]
4. Lipid-metabolizing enzymes, CoASH and long-chain acyl-CoA in rat liver after treatment with tiadenol, nicotinic acid and niadenate.
Bakke OM; Berge RK
Biochem Pharmacol; 1982 Dec; 31(23):3930-3. PubMed ID: 7159471
[No Abstract] [Full Text] [Related]
5. Peroxisome proliferators and cytochrome P4504A induction.
Gibson GG
Ann N Y Acad Sci; 1996 Dec; 804():328-40. PubMed ID: 8993554
[No Abstract] [Full Text] [Related]
6. Zonal heterogeneity of peroxisome proliferation in rat liver.
Fahimi HD; Beier K; Lindauer M; Schad A; Zhan J; Pill J; Rebel W; Völkl A; Baumgart E
Ann N Y Acad Sci; 1996 Dec; 804():341-61. PubMed ID: 8993555
[No Abstract] [Full Text] [Related]
7. Potent peroxisome proliferators inhibit beta-oxidation in the isolated perfused rat liver.
Bojes HK; Thurman RG
Toxicol Appl Pharmacol; 1996 Oct; 140(2):322-7. PubMed ID: 8887448
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of diacylglycerol-activated protein kinase C by acyl-coenzyme A thioesters of hypolipidaemic drugs.
Bronfman M; Orellana A; Morales MN; Bieri F; Waechter F; Stäubli W; Bentley P
Biochem Biophys Res Commun; 1989 Mar; 159(3):1026-31. PubMed ID: 2930549
[TBL] [Abstract][Full Text] [Related]
9. Receptor-mediated mechanisms of peroxisome proliferators.
Green S
Biochem Pharmacol; 1992 Feb; 43(3):393-401. PubMed ID: 1311577
[No Abstract] [Full Text] [Related]
10. Hepatocarcinogenesis of peroxisome proliferators.
Rao MS; Reddy JK
Ann N Y Acad Sci; 1996 Dec; 804():573-87. PubMed ID: 8993574
[No Abstract] [Full Text] [Related]
11. Structural diversity of peroxisome proliferators and their effects on mammalian liver cells in vivo.
de la Iglesia F; McGuire EJ; Haskins JR; Lalwani ND
Ann N Y Acad Sci; 1996 Dec; 804():310-27. PubMed ID: 8993553
[No Abstract] [Full Text] [Related]
12. The effects of hypolipidemic peroxisome proliferators on the induction of sister chromatid exchanges.
Linnainmaa K
Basic Life Sci; 1984; 29 Pt B():965-74. PubMed ID: 6397193
[No Abstract] [Full Text] [Related]
13. Protein phosphorylation by peroxisome proliferators: species-specific stimulation of protein kinases and its role in PP-induced transcriptional activation.
Motojima K; Passilly P; Jannin B; Latruffe N
Ann N Y Acad Sci; 1996 Dec; 804():413-23. PubMed ID: 8993560
[No Abstract] [Full Text] [Related]
14. Mechanism-based risk assessment of peroxisome proliferating rodent hepatocarcinogens.
Williams GM; Perrone C
Ann N Y Acad Sci; 1996 Dec; 804():554-72. PubMed ID: 8993573
[No Abstract] [Full Text] [Related]
15. Effects of ciprofibrate and 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme activities in rats. Relation between hepatic carnitine concentration and carnitine acetyltransferase activity.
Bhuiyan AK; Bartlett K; Sherratt HS; Agius L
Biochem J; 1988 Jul; 253(2):337-43. PubMed ID: 3178716
[TBL] [Abstract][Full Text] [Related]
16. An overview of peroxisome proliferator-induced hepatocarcinogenesis.
Rao MS; Reddy JK
Environ Health Perspect; 1991 Jun; 93():205-9. PubMed ID: 1685443
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment with peroxisome proliferators protects mice against some but not all hepatotoxins.
Nicholls-Grzemski FA; Burcham PC; Calder IC; Priestly BG
Ann N Y Acad Sci; 1996 Dec; 804():742-4. PubMed ID: 8993611
[No Abstract] [Full Text] [Related]
18. Peroxisome proliferators induce high levels of DNA synthesis in primary cultures of rat hepatocytes.
Bell DR; Plant NJ; Horley NJ; Elcombe CR
Ann N Y Acad Sci; 1996 Dec; 804():745-6. PubMed ID: 8993612
[No Abstract] [Full Text] [Related]
19. Role of eicosanoid metabolism in carcinogenesis by peroxisome proliferators.
Glauert HP; Hong JT; Leung LK; Wilson MW
Ann N Y Acad Sci; 1996 Dec; 804():719-21. PubMed ID: 8993604
[No Abstract] [Full Text] [Related]
20. Metabolic requirements for the hepatocellular proliferation induced by peroxisome proliferators. Role of coenzyme A.
Youssef JA; Cunningham ML; Song WO; Badr MZ
Ann N Y Acad Sci; 1996 Dec; 804():725-7. PubMed ID: 8993605
[No Abstract] [Full Text] [Related]
[Next] [New Search]
